| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047001076 |
| P356 | DOI | 10.2165/00003088-198917050-00003 |
| P698 | PubMed publication ID | 2573442 |
| P2093 | author name string | Miners JO | |
| P2860 | cites work | Properties and reactions of salicyl-coenzyme A | Q71735166 |
| Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates | Q71735354 | ||
| Aspirin pharmacokinetics in migraine. The effect of metoclopramide | Q71824733 | ||
| Enzymatic conversion of salicylate to salicylurate | Q71827386 | ||
| Influence of food on aspirin absorption from tablets and buffered solutions | Q71833164 | ||
| Drug biotransformation interactions in man. II. A pharmacokinetic study of the simultaneous conjugation of benzoic and salicylic acids with glycine | Q72381493 | ||
| Inhibition of aspirin absorption by activated charcoal and apomorphine | Q72467404 | ||
| Effect of Corticosteroids on Blood Salicylate Concentration | Q72743578 | ||
| ASPIRIN FORMULATION AND ABSORPTION RATE. II. INFLUENCE ON SERUM LEVELS OF TABLETS, ANTACIDS, AND SOLUTIONS | Q77204536 | ||
| Physicochemical Basis of the Buffered Acetylsalicylic Acid Controversy | Q78823581 | ||
| Presence of Acetylsalicylic Acid in Plasma Following Oral Ingestion of Aspirin | Q78982143 | ||
| Comparison of dissolution and absorption rates of different commercial aspirin tablets | Q79058902 | ||
| Studies on the renal excretion of salicylate in the dog | Q79299341 | ||
| Diflunisal, a New-Acting Analgesic and Prostaglandin Inhibitor: Effect of Concomitant Acetylsalicylic Acid Therapy on Ototoxicity and on Disposition of Both Drugs | Q28323987 | ||
| Intolerance to aspirin. Clinical studies and consideration of its pathogenesis | Q34236999 | ||
| The effect of salicylates on the hemostatic properties of platelets in man | Q34278739 | ||
| Interaction of salicylate and corticosteroids in man. | Q34418013 | ||
| The effect of intra-articular steroids on plasma salicylate concentrations | Q34447141 | ||
| Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid | Q34447873 | ||
| The effect of metoclopramide on the absorption of effervescent aspirin in migraine | Q34451439 | ||
| The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein | Q34481430 | ||
| Influence of sex and oral contraceptive steroids on paracetamol metabolism | Q34513321 | ||
| Interaction between levamisole and aspirin in man | Q34517595 | ||
| The aspirin-ibuprofen interaction in rheumatoid arthritis | Q34518170 | ||
| Clinical pharmacokinetics of salicylates: a re-assessment | Q34519571 | ||
| Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function | Q34551301 | ||
| Aspirin metabolism and efficacy in postoperative dental pain | Q34621226 | ||
| Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination | Q34621539 | ||
| The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites | Q34622717 | ||
| Atenolol interaction with aspirin, allopurinol, and ampicillin | Q34713363 | ||
| Aspirin treatment of migraine attacks: plasma drug level data | Q36648402 | ||
| Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formation | Q37045318 | ||
| Aspirin esterase of gastric mucosal origin | Q39148091 | ||
| Pharmacokinetics of Salicylate in Man | Q39252079 | ||
| Flurbiprofen-aspirin interaction: a double-blind crossover study | Q39457444 | ||
| Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction Studies | Q39558510 | ||
| Interactions of non-steroidal anti-inflammatory drugs | Q39560487 | ||
| Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren | Q39615797 | ||
| Aspirin intolerance--a review | Q39657857 | ||
| Clinical pharmacokinetics of the salicylates | Q39820095 | ||
| Clinical significance of esterases in man. | Q39829565 | ||
| Anti-rheumatic drug interactions | Q40096047 | ||
| Protein binding displacement interactions and their clinical importance | Q40151099 | ||
| Clinical pharmacokinetics of oral activated charcoal in acute intoxications | Q40252013 | ||
| Drug interactions with cimetidine | Q40329702 | ||
| Decreased Serum Salicylate Concentrations in Children with Rheumatic Fever Treated with Antacid | Q40335042 | ||
| Intraindividual Relationships between Serum Protein Binding of Drugs in Normal Human Subjects, Patients with Impaired Renal Function, and Rats | Q40812189 | ||
| Interactions of m-xylene and aspirin metabolism in man. | Q41392091 | ||
| Interaction of isoxicam with acetylsalicylic acid | Q41852588 | ||
| Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole | Q42077449 | ||
| Clinical valproate toxicity induced by acetylsalicylic acid | Q42208284 | ||
| Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation | Q42222596 | ||
| Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man | Q43477434 | ||
| Influence of caffeine on aspirin pharmacokinetics | Q43576477 | ||
| Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man. | Q44461091 | ||
| The incidence of aspirin ingestion in patients with peptic ulcer | Q44632122 | ||
| Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis | Q44839928 | ||
| The effect of aspirin on valproic acid metabolism | Q46215230 | ||
| Naproxen-aspirin interactions in man | Q47879182 | ||
| Kinetics of Aspirin, Salicylic Acid, and Salicyluric Acid following Oral Administration of Aspirin as a Tablet and Two Buffered Solutions | Q51655434 | ||
| Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid | Q52847130 | ||
| Interactions of aspirin with nonsteroidal antiinflammatory drugs in man. | Q54127767 | ||
| Lack of biological interaction of alprenolol and salicylate in man | Q54269891 | ||
| Indomethacin--aspirin interaction: a clinical appraisal | Q55169001 | ||
| Absorption kinetics of aspirin in man following oral administration of an aqueous solution | Q67300357 | ||
| Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man | Q67353760 | ||
| The effect of buffered aspirin on plasma indomethacin | Q67396507 | ||
| Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate | Q67396626 | ||
| Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin | Q67401683 | ||
| Absorption and excretion of tolmetin in man | Q67443838 | ||
| The synergistic effect of salicylates on methotrexate toxicity | Q67456426 | ||
| Interaction of sudoxicam and aspirin in animals and man | Q67511802 | ||
| Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents | Q67696431 | ||
| Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution | Q68749158 | ||
| Absorption of effervescent aspirin during migraine | Q68818701 | ||
| Lowering of plasma isoxicam concentrations with acetylsalicylic acid | Q68967097 | ||
| Transient fall in serum salicylate levels following intraarticular injection of steroid in patients with rheumatoid arthritis | Q68983153 | ||
| Abnormal Aspirin Metabolism in Patients with Cirrhosis and Its Possible Relationship to Bleeding in Cirrhotics | Q69098431 | ||
| The effect of aspirin on serum indomethacin | Q69166748 | ||
| Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man | Q69166774 | ||
| Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis | Q69175360 | ||
| Reversible adsorption (desorption) of aspirin from activated charcoal | Q69264623 | ||
| Effect of concurrent administration of aspirin and indomethacin on serum concentrations | Q69329214 | ||
| Effect of ranitidine on the absorption of aspirin | Q69397880 | ||
| Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man | Q69419287 | ||
| Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis | Q69439864 | ||
| Evaluation of a potential drug interaction between sucralfate and aspirin | Q69609597 | ||
| Pharmacokinetics of salicylates administered with metoprolol | Q69743780 | ||
| The effect of cimetidine on the pharmacokinetics of salicylic acid | Q69798654 | ||
| Drug biotransformation interactions in man. V. Acetaminophen and salicylic acid | Q69955116 | ||
| Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis | Q70334636 | ||
| Effect of activated charcoal on aspirin absorption in man. Part I | Q70374140 | ||
| Kinetics of the digoxin-aspirin combination | Q70449296 | ||
| Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase | Q70503319 | ||
| Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen | Q70507633 | ||
| Urine pH and salicylate therapy | Q70572282 | ||
| Zomepirac--aspirin interactions in man | Q70621552 | ||
| Ketoprofen-aspirin interactions | Q70823719 | ||
| Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man | Q71115737 | ||
| Displacement of phenytoin from plasma binding sites by salicylate | Q71132161 | ||
| Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects | Q71132162 | ||
| Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle | Q71147589 | ||
| The effect of organic acids on renal clearance of methotrexate in man | Q71232539 | ||
| Effect of antacid and ascorbic acid on serum salicylate concentration | Q71269781 | ||
| Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways | Q71295469 | ||
| A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium | Q71397270 | ||
| Phenytoin-salicylate interaction | Q71472643 | ||
| Albumin-binding interactions of sodium valproate | Q71521404 | ||
| Interaction between aspirin and indomethacin in the treatment of rheumatoid arthritis | Q71533768 | ||
| Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects | Q71600930 | ||
| P433 | issue | 5 | |
| P921 | main subject | aspirin | Q18216 |
| P304 | page(s) | 327-344 | |
| P577 | publication date | 1989-11-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid | |
| P478 | volume | 17 |
| Q40886062 | Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance |
| Q44790474 | Aspirin alters methotrexate disposition in rheumatoid arthritis patients |
| Q37542357 | Aspirin for primary prevention: do potential benefits outweigh the risks? |
| Q42916642 | Aspirin potentiates blood glucose lowering effect of glimepiride-pioglitazone combination in streptozotocin-induced diabetic rats |
| Q33908232 | Auditory sensori-neural alterations induced by salicylate |
| Q28209075 | Dietary salicylates |
| Q44211488 | Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate. |
| Q41678694 | Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial |
| Q28194378 | Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe |
| Q37702261 | Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers. |
| Q91692899 | Fiber-Array-Based Raman Hyperspectral Imaging for Simultaneous, Chemically-Selective Monitoring of Particle Size and Shape of Active Ingredients in Analgesic Tablets |
| Q34109232 | Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin |
| Q28196281 | Metabolic interactions between acetylsalicylic acid and benzene |
| Q46075640 | Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients |
| Q34723818 | Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs |
| Q36662888 | Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments |
| Q38172305 | Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection |
| Q42538829 | Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes |
| Q35953662 | Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it |
| Q37577775 | The challenge of pain management in patients with myasthenia gravis. |
| Q42778171 | The effect of aspirin nanoemulsion on TNFα and iNOS in gastric tissue in comparison with conventional aspirin |
| Q34403115 | The influence of gastrointestinal transit on drug absorption in healthy volunteers |
| Q44765800 | Transient ischemic attack reported with paroxetine use. |
| Q40466066 | What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions? |
| Q73672318 | [Pharmacology of aspirin] |
Search more.